|
||
|
Albumin-DX Reduces non-specific binding, improves specificity, consistent, outperforms BSA and pHSA, regulatory friendly, enhances stability.
|
||
Albumin DX-Lipid Reduced – Recombinant albumin diagnostic blocking reagent.Albumin DX-LR reduces non-specific binding and cross reactivity, enhances biomarker stability and is free of any immunoglobulin or proteases.Serum albumin is a common blocking reagent used in diagnostic applications. Since Albumin DX-LR is recombinant albumin produced in a completely animal-free system, it is immunoglobulin and protease free. This reduces non-specific binding and cross reactivity thus improving specificity and reproducible results. In addition, Albumin DX-LR improves the stability of antibodies and analytes. Unlike bovine albumin or human serum albumin, Albumin DX-LR is a consistent reagent with no lot-to-lot variability or concerns about occupational safety, which arise with animal or human blood products. Being an animal and human free product also eliminates additional regulatory requirements associated with the import or export of blood products. Research has shown that Albumin DX-LR outperforms both bovine albumin and human serum albumin and is a cost-effective way to improve diagnostic performance. Advantages
Comparative Data
Albumin-DX Lipid-Reduced showed more stable biomarker activity over 96 hours compared to a commercial diluent. For more information, please call 1-800-916-8311 or email us Product Technical Documents:Other Documents:
|
||


